FDA Issues Guidelines On Wireless Medical Devices
FDA outlines risks such as lost signals and recommends stringent security measures -- but document is not the last regulatory word.
The Food and Drug Administration (FDA) has released final guidelines on the design, testing and use of radio-frequency (RF) wireless medical devices. Although it doesn't promulgate legally enforceable responsibilities, the document is intended to guide both device manufacturers and healthcare providers toward the safe and secure use of wireless medical devices. Covered are devices "that are implanted, worn on the body or other external wireless medical devices intended for use in hospitals, homes, clinics, clinical laboratories, and blood establishments."
The FDA document has no relation to the impending guidance from the agency about how it will regulate apps that turn smartphones and tablets into medical devices. In fact, the draft guidance on RF wireless devices was issued in 2007, before smartphones and tablets became a factor in the industry. The FDA is focusing on the safety aspects of medical devices in hospitals, homes and other fixed-care settings.
More Security Insights
- Forrester Study: The Total Economic Impact of VMware View
- Securing Executives and Highly Sensitive Documents of Corporations Globally
- State of Cloud 2011: Time for Process Maturation
- Research: Federal Government Cloud Computing Survey
- Closing the Book on Windows Server 2003: Planning for Windows Server 2012 Opens New Possibilities
- Smarter Process: Five Ways to Make Your Day-to-Day Operations Better, Faster and More Measurable
For example, the guidance states, "Because there are risks associated with RF wireless systems, we recommend that you carefully consider which device functions should be made wireless and which device functions should employ wired connectivity."
Read the full article here.
Have a comment on this story? Please click "Discuss" below. If you'd like to contact Dark Reading's editors directly, send us a message.